Literature DB >> 22851227

Participation of Gab1 and Gab2 in IL-22-mediated keratinocyte proliferation, migration, and differentiation.

Xiaofang Zhu1, Zhongliang Li, Wenyan Pan, Lu Qin, Guoqiang Zhu, Yuehai Ke, Jie Wu, Ping Bo, Songshu Meng.   

Abstract

Interleukin-22 (IL-22) is one of the key mediators of keratinocyte alterations in psoriasis. IL-22 inhibits keratinocyte differentiation and induces the migration of human keratinocytes. Grb2-associated binder 1 (Gab1) has been shown to mediate epidermal growth factor-induced epidermal growth and differentiation via interaction with the Src homology-2-containing protein-tyrosine phosphatase (Shp2). In this investigation, we explore the role of Gab1 and Gab2 in IL-22-mediated keratinocyte activities. We show that both Gab1 and Gab2 were tyrosine phosphorylated in IL-22-stimulated HaCaT cells and human primary epidermal keratinocytes and contributed to the activation of Extracellular signal regulated kinase 1/2 (Erk1/2) through interaction with Shp2. We further demonstrate that HaCaT cells infected with adenoviruses expressing Shp2-binding-defective Gab1/2 mutants exhibited decreased cell proliferation and migration, as well as increased differentiation. Moreover, similar results were observed in HaCaT cells infected with adenovirus-based small interfering RNAs targeting Gab1 and/or Gab2. Altogether, these data underscore the critical roles of Gab1 and Gab2 in IL-22-mediated HaCaT cell proliferation, migration, and differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851227     DOI: 10.1007/s11010-012-1389-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor.

Authors:  Anders Kallin; Jean-Baptiste Demoulin; Keigo Nishida; Toshio Hirano; Lars Rönnstrand; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

2.  The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin.

Authors:  C Johansen; K Kragballe; M Westergaard; J Henningsen; K Kristiansen; L Iversen
Journal:  Br J Dermatol       Date:  2005-01       Impact factor: 9.302

3.  Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor.

Authors:  J M Cunnick; J F Dorsey; T Munoz-Antonia; L Mei; J Wu
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

Review 4.  Recent advances in IL-22 biology.

Authors:  Lauren A Zenewicz; Richard A Flavell
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

5.  Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.

Authors:  Christine Caron; Kathleen Spring; Mélanie Laramée; Catherine Chabot; Monikca Cloutier; Haihua Gu; Isabelle Royal
Journal:  Cell Signal       Date:  2009-02-20       Impact factor: 4.315

6.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

8.  The involvement of Gab1 and PI 3-kinase in beta1 integrin signaling in keratinocytes.

Authors:  Yoshihiro Kuwano; Manabu Fujimoto; Rei Watanabe; Nobuko Ishiura; Hiroko Nakashima; Mayumi Komine; Tatsuo S Hamazaki; Kunihiko Tamaki; Hitoshi Okochi
Journal:  Biochem Biophys Res Commun       Date:  2007-07-16       Impact factor: 3.575

9.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

10.  Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes.

Authors:  D Gutowska-Owsiak; A L Schaupp; M Salimi; S Taylor; G S Ogg
Journal:  Br J Dermatol       Date:  2011-07-11       Impact factor: 9.302

View more
  14 in total

1.  IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling.

Authors:  Yinghua Ji; Xiaoyu Yang; Jinsong Li; Zhihong Lu; Xiaorui Li; Jian Yu; Na Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 2.  Biological and pathological activities of interleukin-22.

Authors:  Mirna Perusina Lanfranca; Yanwei Lin; Jingyuan Fang; Weiping Zou; Timothy Frankel
Journal:  J Mol Med (Berl)       Date:  2016-02-29       Impact factor: 4.599

Review 3.  Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.

Authors:  Alexis L Santana; Diane Felsen; John A Carucci
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

4.  Scaffolding protein Gab1 regulates myeloid dendritic cell migration in allergic asthma.

Authors:  Yun Zhang; Yun Xu; Shuwan Liu; Xiaohong Guo; Dong Cen; Jiaqi Xu; Heyuan Li; Kaijun Li; Chunlai Zeng; Linrong Lu; Yiting Zhou; Huahao Shen; Hongqiang Cheng; Xue Zhang; Yuehai Ke
Journal:  Cell Res       Date:  2016-11-04       Impact factor: 25.617

Review 5.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

6.  Genetic Basis of Irritant Susceptibility in Health Care Workers.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; M Michael Barmada; Victor J Johnson; Michael L Kashon; Elma Baron; Nevin W Wilson; Bonnie Frye; Wei Wang; Kara Fluharty; Rola Gharib; Jean Meade; Dori Germolec; Michael I Luster; Susan Nedorost
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

Review 7.  Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.

Authors:  Elena Campione; Caterina Lanna; Laura Diluvio; Maria Vittoria Cannizzaro; Sandro Grelli; Marco Galluzzo; Marina Talamonti; Margherita Annicchiarico-Petruzzelli; Mara Mancini; Gerry Melino; Eleonora Candi; Gianfranco Schiavone; Ying Wang; Yufang Shi; Luca Bianchi
Journal:  Cell Cycle       Date:  2020-01-05       Impact factor: 4.534

Review 8.  Therapeutic opportunities of the IL-22-IL-22R1 system.

Authors:  Robert Sabat; Wenjun Ouyang; Kerstin Wolk
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

9.  The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune Uveitis.

Authors:  Yejin Kim; Tae Wan Kim; Yun Seong Park; Eui Man Jeong; Dong-Sup Lee; In-Gyu Kim; Hum Chung; Young-Il Hwang; Wang Jae Lee; Hyeong Gon Yu; Jae Seung Kang
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

10.  Interleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cells.

Authors:  Zhiyong Wu; Zhipeng Hu; Xin Cai; Wei Ren; Feifeng Dai; Huagang Liu; Jinxing Chang; Bowen Li
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.